Mada Hashem1,2,3,4,5, Ying Wu1,3,4,5, and Jeff F. Dunn1,2,3,4,5
1Department of Radiology, University of Calgary, Calgary, AB, Canada, 2Biomedical Engineering Graduate Program, University of Calgary, Calgary, AB, Canada, 3Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada, 4Experimental Imaging Centre, University of Calgary, Calgary, AB, Canada, 5Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
Synopsis
Non-invasive quantitative imaging
of cerebral oxygen consumption is crucial to understand the involvement of
oxidative metabolism in neurological diseases. We are applying a novel
multimodal technique combining near-infrared spectroscopy and high-field MRI to
study the mitochondrial status as well as oxygen delivery and consumption in
the cortex of the cuprizone mouse model. In this study, multiple physiological
parameters controlling oxidative metabolism were investigated in the cuprizone
mice exhibiting demyelination. A mitochondrial impairment and a reduced oxygen
consumption rate were found in the gray matter of cuprizone mice, emphasizing
the association between abnormal oxidative metabolism and the observed
demyelination.
INTRODUCTION
Disruptions in oxidative metabolism may occur in neurological diseases,
such as Multiple Sclerosis (MS)1,2, Alzheimer's Disease3, Parkinson’s disease4. Non-invasive examination of oxidative metabolism
and the multiple physiological parameters involved in this process, such as oxygenation
levels, dynamics of the blood flow, and mitochondrial status, is crucial to further
understand the role of these parameters in neurological diseases. We are implementing a novel multimodal imaging technique combining
Near-infrared Spectroscopy (NIRS) and MRI to study simultaneously, and
non-invasively, physiological alterations in the brain of mouse models. Using
this technique, we are monitoring oxygenation (StO2) and mitochondrial capacity
focusing on the key enzyme Cytochrome C Oxidase (CCO), while providing
information on the process of blood delivery (CBF) and O2
consumption (CMRO2) throughout the brain of the cuprizone mouse
model. This is a well-known model for the study of demyelination and
spontaneous remyelination, which is also useful to study human MS5.METHODS
Twenty
C57BL/6J male mice (8-week-old) were separated
into Control (n = 9) and Cuprizone (n = 11) groups.
Control mice received normal mouse chow, while cuprizone mice received a diet
of ground chow mixed with cuprizone6. After 5 weeks, cuprizone diet was
terminated, and the Cuprizone group was given normal diet for 4 additional
weeks, for recovery.
NIRS-MRI imaging were performed for both
groups prior to the cuprizone diet initiation (Week 0), at the end of the
cuprizone exposure (Week 5) and after cuprizone cessation (Week 9). Statistical analysis was performed
comparing CPZ and CTRL groups over 3 different time points using mixed
factorial ANOVA with Bonferroni post-hoc test. During
imaging, the mice were spontaneously ventilated with a gas mixture of 70% N2
and 30% O2 in addition to 2% isoflurane.
A 9.4T MRI with a 35mm volume coil was used
to quantify Magnetization Transfer Ratio (MTR) as a marker for de/remyelination.
A single axial slice was acquired using a spin-echo sequence with the following
parameters: TR/TE=2500/15 ms, FOV=12.8x12.8 mm, voxel resolution=100x100x1500
µm3. 40 MT pulses of Gauss shape were applied. The MT pulse B1
strength was 10.0 µT with 15 ms duration, 1ms interpulse delay, 182.7 Hz
bandwidth, and an offset frequency of 1500 Hz. An identical reference magnitude
image, M0, was collected with no MT pulse. In total, two images
(with and without MT pulse) were collected over a period of 12 min, and MTR
maps were generated. ROI were selected within the corpus callosum and cerebral
cortex.
For perfusion measurement, the same slice was
acquired using a CASL-HASTE sequence with the following parameters: TR/TE=3000/13.5 ms,
FOV=25.6×25.6 mm, matrix size=128×128 pixels, slice thickness=1.5 mm, 16
averages. Four perfusion images were collected per measurement: 2 control
images and 2 tagged images, to correct for magnetization transfer. Following
these images, a T1 map was obtained in the same location using a RARE-VTR
sequence where effective TE=20 ms, TR=100, 500, 1000, 3000, and 7500 ms.
Together, the four perfusion images and the T1 map were collected over a period
of 14 min. CBF was calculated on a voxel-by-voxel basis7.
In addition, a
two-dimensional T2-weighted RARE sequence was acquired with
TR/TE=3000/32 ms, FOV=25.6x25.6 mm, matrix size=256x256, voxel
resolution=100x100 µm2, slice thickness=0.5 mm, 10
averages, and acquisition time=16 min.
We measured
the concentration of hemoglobin and StO2
in mouse cortex, in addition to the concentration and redox state of CCO using
a custom-built broadband NIRS device and in-house developed processing
algorithms. CMRO2 was calculated based on the modified
Fick principle8.
RESULTS
Cuprizone mice showed reduced OEF (31.8%,
p≤0.05) and CMRO2 (47.2%, p≤0.001) that were resolved after
cessation of cuprizone exposure, in addition to a decrease in hemoglobin
concentration (28.42%, p≤0.05), an increase in tissue oxygenation (5.7%,
p≤0.05) but no change in CBF. The oxidized state of CCO increased (36.9%,
p≤0.01) significantly in cuprizone mice while the reduced state decreased (34.4%,
p≤0.05). The total amount of the enzyme was not affected by the cuprizone diet,
however, it decreased at week 9 both in control (23.1%, p≤0.01) and cuprizone
(28.8%, p≤0.01) groups. A reduced value of MTR at week 5 was observed in the
cuprizone group both in cerebral cortex (3.2%, p≤0.05) and corpus callosum
(5.1%, p≤0.001). T2-weighted images of cuprizone mice showed a
strong gray-white matter contrast which decreased at week 5 and increased back
after recovery.DISCUSSION
Higher
levels of oxidized CCO were found in cuprizone mice, which could be an
adaptation in response to an impairment in the electron transport chain. The
abnormal redox state of CCO led to lower O2 extraction fraction,
lower O2 consumption rate by the tissue, and thus a higher O2
availability (StO2) in cortical microvessels. These
metabolic changes were associated with the impaired myelination occurring in
the gray matter (GM) as well as the white matter of the cuprizone mouse model.CONCLUSION
We were able to detect significant
metabolic alterations in the GM of cuprizone mice using novel NIRS-MRI
multimodality system. Demyelination and possible mitochondrial involvement were
supported by reduced MTR, increased redox state of CCO, and reduced
CMRO2. The novel multimodal imaging technique applied here shows promise
for noninvasively assessing parameters associated with oxidative metabolism in both
mouse models of neurological disease and for translation to study oxidative
metabolism in human brain. Acknowledgements
This work was
supported by an NIH R21 grant, Canada Foundation for Innovation (CFI), Natural
Sciences and Engineering Research Council (NSERC), Discovery grant, and the
Biomedical Engineering Graduate Program (BMEG) at U of C.References
1. Lin
MT, Beal MF. Mitochondrial dysfunction and oxidative stress in
neurodegenerative diseases. Nature. 2006;443(7113):787-795.
2. Mahad D, Ziabreva I,
Lassmann H, Turnbull D. Mitochondrial defects in acute multiple sclerosis
lesions. Brain: a journal of neurology. Jul
2008;131(Pt 7):1722-1735.
3. Moreira PI, Carvalho
C, Zhu X, Smith MA, Perry G. Mitochondrial dysfunction is a trigger of
Alzheimer's disease pathophysiology. Biochimica
et Biophysica Acta (BBA)-Molecular Basis of Disease. 2010;1802(1):2-10.
4. Cai H, Cong W-n, Ji
S, Rothman S, Maudsley S, Martin B. Metabolic dysfunction in Alzheimer's
disease and related neurodegenerative disorders. Current Alzheimer research. 2012;9(1):5-17.
5. Praet J,
Guglielmetti C, Berneman Z, Van der Linden A, Ponsaerts P. Cellular and
molecular neuropathology of the cuprizone mouse model: clinical relevance for
multiple sclerosis. Neuroscience &
Biobehavioral Reviews. 2014;47:485-505.
6. Ghaiad HR, Nooh MM,
El-Sawalhi MM, Shaheen AA. Resveratrol promotes remyelination in cuprizone
model of multiple sclerosis: Biochemical and histological study. Molecular neurobiology. 2017;54(5):3219-3229.
7. Buxton RB.
Quantifying CBF with arterial spin labeling. Journal of magnetic resonance imaging : JMRI. Dec
2005;22(6):723-726.
8. Tichauer KM, Hadway
JA, Lee T-Y, Lawrence KS. Measurement of Cerebral Oxidative Metabolism with
Near-Infrared Spectroscopy: A Validation Study. Journal of Cerebral Blood Flow & Metabolism. 2006;26(5):722-730.